Comparative analysis of fingolimod versus teriflunomide in relapsing–remitting multiple sclerosis - Boz, Cavit; Terzi, Murat; Özer, Bilge; Turkoglu, Recai; Karabudak, Rana; Efendi, Hüsnü; Soysal, Aysun; Sevim, Serhan; Altintas, Ayse; Kurne, Asli; Akçalı, Aylin; Akman, Gülsen; et al. (Multiple sclerosis and related disorders, 2019)
Keywords: Adult; Crotonates - administration & dosage; Crotonates - pharmacology; Female; Fingolimod Hydrochloride - administration & dosage; Fingolimod Hydrochloride - pharmacology; Humans; Immunologic Factors - administration & dosage; Immunologic Factors - pharmacology; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting - diagnostic imaging; Multiple Sclerosis, Relapsing-Remitting - drug therapy; Multiple Sclerosis, Relapsing-Remitting - physiopathology; Neurology; Outcome Assessment, Health Care; Propensity Score; Retrospective Studies; Secondary Prevention; Severity of Illness Index; Toluidines - administration & dosage; Toluidines - pharmacology